Dr. Judd Moul, professor of surgery and director of the Duke Prostate Center, was quoted in a recent NYTimes article. For the first time, two independent clinical trials have showed that two different drugs give certain patients about two more years before their cancer metastasizes. “‘We’re going from rags to riches,'” says Dr. Moul. Read the full article here.
NYTimes: “Two Prostate Cancer Drugs Delay Spread of the Disease by Two Years”
Search Posts
YOU MAY ALSO LIKE
Related Posts
Productivity is the engine that powers thriving organizations, but HR and benefits leaders across industries are facing a quiet but...
You’ve built a competitive and comprehensive benefits suite. But if your employees aren’t using it, how much is it really...
Managing rising costs remains one of the most pressing challenges for HR and benefits leaders. Yet while attention often focuses...
For HR and benefits leaders, managing workforce health has never been more critical or complex. Chronic and complex conditions are...